Skip to main content Accessibility help
×
Home

Disclosing the extensive crystal chemistry of Ivabradine hydrochloride, in its pure and solvated phases

  • N. Masciocchi (a1), A. Aulisio (a1), G. Bertolini (a2), M. Sada (a2), F. Garis (a2) and L. Malpezzi (a3)...

Abstract

Powder diffraction data are presented for Ivabradine hydrochloride (pure and solvated forms), a drug marketed worldwide for symptomatic treatment of angina pectoris and inappropriate sinus tachycardia. [Ivrabradine: 3-[3-({[(7S)-3,4-dimethoxy bicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}(methyl)amino)propyl]-7,8-dimethoxy-2,3,4,5-tetrahydro-1H-3-benzazepin-2-one]. Many are the different (polymorphic or solvated) phases claimed in the scientific or forensic literature. We have here prepared monophasic samples of six different ivabradine hydrochloride species. Exposure to water vapours, at room temperature, of the anhydrous δ-d form generated pure powders of the tetrahydrate form (the β-form). Two different anhydrous forms (β-d and α) were prepared by gentle, or extensive, heating of the β and δ-d forms, respectively. Acetonitrile and acetone solvates (hereafter called δ1- and δ2-forms) were obtained by precipitation methods from concentrated solutions. Diffraction data were collected on laboratory equipment with Ni-filtered Cu radiation; cell parameters and space groups were determined from ab initio indexing procedures using the SVD algorithm.

Copyright

Corresponding author

a) Author to whom correspondence should be addressed. Electronic mail: norberto.masciocchi@uninsubria.it

References

Hide All
Cheary, R. W. and Coelho, A. (1992). “A fundamental parameters approach to X-ray line profile fitting”, J. Appl. Crystallogr. 25, 109121.
Coelho, A. (2003). “Indexing of powder diffraction patterns by iterative use of singular value decomposition”, J. Appl. Crystallogr. 36, 8595.
De Wolff, P. M. (1972). “A simplified criterion for the reliability of a powder pattern indexing”, J. Appl. Crystallogr., 1, 108113.
Duval, D., Hennig, P., Bouchet, J. P., Vian, J., Peglion, J. L., Volland, G. P., Platzer, N., and Guilhem, J. (1997). “Stereochemical study of bradicardisant benzazepine-type drug. X-ray structure of the chloride salt and high-field NMR study of the stereochemistry in solution”, Magn. Res. Chem. 35, 175183.
Dwivedi, S. D., Kumar, R., Patel, S. T., and Shah, A. P. C. (2008). “Process for preparation of ivabradine hydrochloride” International Patent WO 065681 A2, (δ-d-form).
Horvath, S., Auguste, M.-N., and Damien, G. (2006). “Beta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it” US Patent 0194962 A1.
Horvath, S., Auguste, M.-N., and Damien, G. (2007). “Delta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it” US Patent 0082885 A1.
Horvath, S., Auguste, M.-N., and Damien, G. (2011). “β D-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it” US Patent 7867995.
Singh, S. P., Singh, G., and Wadhwa, L. (2012). “Crystalline ivabradine oxalate salts and polymorphs thereof”, European Patent EP 2471780 (α-form).
TOPAS-R, v. 3.0, (2005). Bruker AXS, Karlsruhe, Germany
Wieser, J., Griesser, U., Enders, M., and Kahlenberg, V. (2013). “Acetone solvate of ivabradine hydrochloride”, Patent WO2013/017582.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed